NCT04978675View on ClinicalTrials.gov

An Investigational Scan (rh PSMA 7.3 PET/MRI) for the Detection of Recurrent Disease and Aid in Radiotherapy Planning in Biochemically Recurrent Prostate Cancer

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 4, 2021

Primary Completion Date

June 4, 2024

Study Completion Date

June 4, 2024

Conditions

Biochemically Recurrent Prostate CarcinomaLocalized Prostate CarcinomaProstate Adenocarcinoma

Interventions

DRUG

Fluorine F 18 rhPSMA-7.3

Given IV

PROCEDURE

Magnetic Resonance Imaging

Undergo PET/MRI

PROCEDURE

Positron Emission Tomography

Undergo PET/MRI

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors

lead

M.D. Anderson Cancer Center

OTHER

NCT04978675 - An Investigational Scan (rh PSMA 7.3 PET/MRI) for the Detection of Recurrent Disease and Aid in Radiotherapy Planning in Biochemically Recurrent Prostate Cancer | Biotech Hunter | Biotech Hunter